Skip to content
Home/Companies/Biotech/Arsenale

Arsenale

Biotech·Italy·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Arsenale?

Arsenale is an Italian Biotech company, currently owned by byFounders since 2025.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
byFounders
Investor
byFounders
byFounders III · 2023 · VC

Key facts

HQItaly
SectorBiotech
StatusActive

More from byFounders III

Other portfolio companies in the same fund.

Apylon
Active
SaaSDenmark· 2026
Cloudgeni
Active
Cloud InfrastructureNorway· 2026
Flare
Flare
Active
AI/MLDenmark· 2026
Fload
Active
SaaSUnited Arab Emirates· 2026
Spiral Hydrogen
Active
ClimateTechEstonia· 2026
Tangled
Active
DevToolsFinland· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Arsenale?

Arsenale is currently owned by byFounders, through byFounders III, since 2025.

When did byFounders acquire Arsenale?

byFounders acquired Arsenale in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue